Healthcare -
Biotechnology - NASDAQ - US
$ 85.3
-2.88 %
$ 10.6 B
Market Cap
-18.87
P/E
PCVX - CAPITAL EXPENDITURES
Capital Expenditures PCVX - Vaxcyte, Inc.
-67.9 M
LAST VALUE
-221.79%
2 YEAR CAGR
-107.28%
5 YEAR CAGR
0.00%
10 YEAR CAGR